Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood–brain barrier (BBB)
Top Cited Papers
- 28 February 2009
- journal article
- Published by Elsevier BV in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 71 (2), 251-256
- https://doi.org/10.1016/j.ejpb.2008.08.021
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Chemotherapy of brain tumour using doxorubicin bound to surfactant-coated poly(butyl cyanoacrylate) nanoparticles: Revisiting the role of surfactantsJournal of Controlled Release, 2007
- Covalent Linkage of Apolipoprotein E to Albumin Nanoparticles Strongly Enhances Drug Transport into the BrainJournal of Pharmacology and Experimental Therapeutics, 2006
- Nanoparticles as Drug Delivery Systems for the BrainPublished by Taylor & Francis Ltd ,2005
- Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseasesProgress in Neurobiology, 2005
- Delivery of β-Galactosidase to Mouse Brain via the Blood-Brain Barrier Transferrin ReceptorThe Journal of pharmacology and experimental therapeutics, 2005
- Intravenous, non-viral RNAi gene therapy of brain cancerExpert Opinion on Biological Therapy, 2004
- Chemotherapy of glioblastoma in rats using doxorubicin‐loaded nanoparticlesInternational Journal of Cancer, 2004
- Understanding and circumventing the blood‐brain barrierActa Paediatrica, 2003
- Nanoparticulate systems for brain delivery of drugsAdvanced Drug Delivery Reviews, 2001
- Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles)Brain Research, 1995